Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
|Podcasts|January 20, 2021
COVID-19 in pregnancy: Q&A with Emily Adhikari, MD
Author(s)Lindsey Carr, Editor
On this episode of Pap Talk, Emily Adhikari, MD answers frequently asked questions about the COVID-19 vaccine.
Advertisement
Emily Adhikari, MD is the medical director of Perinatal Infectious Diseases, and assistant professor of Obstetrics and Gynecology in the division of Maternal-Fetal Medicine at the University of Texas Southwestern Medical Center in Dallas.
Advertisement
Related to this article
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
3
Perimenopause and mental health: Beyond hormonal vs psychological
4
Real-world data link fezolinetant to fewer nighttime awakenings
5